RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Tiltbio

Tiltbio

TILT Biotherapeutics is a clinical-stage biotechnology company creating the next generation of immunotherapies for solid tumors.

Latest funding

$25M Series B+ ·

Source: fundraisingfox.com

Funding history ↓
Website: tiltbio.com.
Category: Health and bio.
Stage: Series B+.
Last round: May 13, 2025 · 552 days ago.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredMay 30, 2013 (13 years old)

Funding rounds

DateRoundAmountLeadSource
Series B+$25M—fundraisingfox.com

Timeline

  1. Website created

Founders and team

Companies like Tiltbio

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/tiltbio (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy